Thursday, December 8, 2011

Neurology - Dementia Article | Vitamin D-Mentia: Randomized Clinical Trials Should Be the Next Step

Neurology - Dementia Article | Vitamin D-Mentia: Randomized Clinical Trials Should Be the Next Step

Annweiler C et al. – Hypovitaminosis D is highly prevalent in the elderly. Its possible role in the pathogenesis of Alzheimer’s disease (AD) is particularly important, as AD remains a public health concern with no current efficient treatment. Vitamin D administration could be a multitarget stabilizing treatment for AD since vitamin D simultaneously targets several factors leading to neurodegeneration through immunoregulatory, antioxidant and anti-ischemic actions, as well as the regulation of neurotrophic factors, acetylcholine neurotransmitter and clearance of amyloid beta peptide, and the avoidance of hyperparathyroidism.

Neuroepidemiology , 12/08/2011 Clinical Article

No comments:

Post a Comment